首页> 外文期刊>Modern Pathology >Loss of heterozygosity on tuberous sclerosis complex genes in multifocal micronodular pneumocyte hyperplasia
【24h】

Loss of heterozygosity on tuberous sclerosis complex genes in multifocal micronodular pneumocyte hyperplasia

机译:多灶性微结节性肺细胞增生的结节性硬化复合基因杂合性丧失

获取原文
           

摘要

Multifocal micronodular pneumocyte hyperplasia is a rare pulmonary manifestation of tuberous sclerosis complex (TSC) that is a tumor suppressor gene disorder characterized by many hamartomas. A purported mechanism of hamartomatous proliferation in TSC is constitutive activation of the mammalian target of rapamycin (mTOR) signaling pathway dysregulated by a functional loss of TSC genes. Although multifocal micronodular pneumocyte hyperplasia develops locally as self-limited, benign lesions, it is morphologically similar to the preinvasive lesion of pneumocytes that characterize atypical adenomatous hyperplasia or bronchioloalveolar carcinoma. Frequently both conditions include a loss of heterozygosity on TSC. The goal of this study was to determine whether multifocal micronodular pneumocyte hyperplasia is neoplastic. Loss of heterozygosity on TSC genes and immunohistochemistry for mTOR-related proteins (phospho-mTOR, phospho-p70S6K, phospho-S6, and phospho-Akt) were analyzed in 42 lesions: 16 multifocal micronodular pneumocyte hyperplasia (7 patients with TSC, 1 TSC not confirmed), 14 atypical adenomatous hyperplasia, and 12 bronchioloalveolar carcinoma (9 and 12 patients, respectively). The results showed that at least one of two multifocal micronodular pneumocyte hyperplasia lesions from each patient had loss of heterozygosity on TSC1 or TSC2 (15 or 50%) and were frequently immunopositive for phospho-mTOR (88%), phospho-p70S6K (100%), and phospho-S6 (100%) but not phospho-Akt (14%), an upstream regulatory protein of mTOR. Loss of heterozygosity of TSC was found in the preinvasive lesions of pneumocytes, equal to or less than multifocal micronodular pneumocyte hyperplasia. In contrast, phospho-Akt was expressed in the preinvasive lesions of pneumocytes more frequently than multifocal micronodular pneumocyte hyperplasia, but the other mTOR-related proteins were less frequently expressed in the former than in the latter. These outcomes suggest that functional loss of TSCs and consequent hyperphosphorylation of mTOR-related proteins in multifocal micronodular pneumocyte hyperplasia may cause its benign neoplastic proliferation of pneumocytes.
机译:多灶性微结节性肺细胞增生是结节性硬化症(TSC)的罕见肺部表现,它是一种以许多错构瘤为特征的抑癌基因疾病。 TSC中错构瘤增殖的一种据称机制是雷帕霉素(mTOR)信号转导途径的哺乳动物靶标的组成性激活,该靶标受TSC基因功能丧失的调节。尽管多灶性微结节性肺细胞增生局部发展为自限性良性病变,但其形态学上类似于表现为非典型腺瘤性增生或支气管肺泡癌的肺细胞浸润前病变。通常,两种情况都包括TSC杂合性的丧失。这项研究的目的是确定多灶性微结节性肺细胞增生是否为赘生性。在42个病变中分析了mTOR相关蛋白(phospho-mTOR,phospho-p70S6K,phospho-S6和phospho-Akt)在TSC基因上的杂合性丧失和免疫组化:16种多灶性微结节性肺细胞增生(7例TSC,1例TSC未确认),14例非典型腺瘤性增生和12例支气管肺泡癌(分别为9例和12例)。结果显示,每位患者的两个多灶性微结节性肺细胞增生性病变中至少有一个在TSC1或TSC2上丧失杂合性(15或50%),并且经常对磷酸化mTOR(88%),磷酸化p70S6K( 100%)和磷酸S6(100%),而不是磷酸Akt(14%),这是mTOR的上游调节蛋白。 TSC杂合性的丧失在肺细胞的浸润前病变中发现,等于或小于多灶性微结节性肺细胞增生。相反,磷酸化-Akt在多发性微结节性肺细胞增生中在肺细胞的浸润前病变中更频繁地表达,但其他mTOR相关蛋白在前者中的表达频率比后者低。这些结果表明,多灶性微结节性肺细胞增生中TSC的功能丧失和mTOR相关蛋白的过度磷酸化可能导致其良性肿瘤性肺细胞增殖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号